The following table sets forth the computation of the basic and diluted net loss per share (in thousands, except share and per share amounts):


	Three Months Ended June 30,						Six Months Ended June 30,
	2026			2025			2026			2025
Numerator:
Net loss attributable to common stockholders	$	(8,185	)	$	(6,462	)	$	(18,213	)	$	(17,111	)
Denominator:
Weighted-average common shares outstanding used to calculate net loss per share attributable to common stockholders, basic and diluted		44,760,766			30,172,328			39,439,881			30,113,321
Net loss per share attributable to common stockholders, basic and diluted	$	(0.18	)	$	(0.21	)	$	(0.46	)	$	(0.57	)

Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potential common shares outstanding would have been anti-dilutive. Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows:


	June 30,
	2026		2025
Options issued and outstanding		6,418,947		5,890,920
Unvested RSUs		1,272,029		927,468
Estimated shares issuable under the ESPP		10,779		35,239
Total		7,701,755		6,853,627

The 8,741,493 shares of common stock that may be issued upon exercise of the Pre-Funded Warrants issued under the 2025 Exchange Agreements and the 2026 Private Placement (see Note 8) are considered outstanding for the purposes of computing earnings per share because the shares may be issued for little or no consideration, they are fully vested and the Warrants are immediately exercisable upon their issuance date.